Roes KC - Search Results

1

Interpretation and inference in noninferiority randomized controlled trials in drug research.

Wangge G, Klungel OH, Roes KC, de Boer A, Hoes AW, Knol MJ. Wangge G, et al. Among authors: roes kc. Clin Pharmacol Ther. 2010 Sep;88(3):420-3. doi: 10.1038/clpt.2010.134. Epub 2010 Jul 28. Clin Pharmacol Ther. 2010. PMID: 20668448

2

Room for improvement in conducting and reporting non-inferiority randomized controlled trials on drugs: a systematic review.

Wangge G, Klungel OH, Roes KC, de Boer A, Hoes AW, Knol MJ. Wangge G, et al. Among authors: roes kc. PLoS One. 2010 Oct 27;5(10):e13550. doi: 10.1371/journal.pone.0013550. PLoS One. 2010. PMID: 21048948 Free PMC article. Review.

3

Validation and predictive performance assessment of clinical trial simulation models.

Boessen R, Knol MJ, Groenwold RH, Roes KC. Boessen R, et al. Among authors: roes kc. Clin Pharmacol Ther. 2011 Apr;89(4):487-8; author reply 488. doi: 10.1038/clpt.2010.277. Epub 2011 Feb 16. Clin Pharmacol Ther. 2011. PMID: 21326289 No abstract available.

4

Pharmacogenetics in randomized controlled trials: considerations for trial design.

van der Baan FH, Klungel OH, Egberts AC, Leufkens HG, Grobbee DE, Roes KC, Knol MJ. van der Baan FH, et al. Among authors: roes kc. Pharmacogenomics. 2011 Oct;12(10):1485-92. doi: 10.2217/pgs.11.95. Pharmacogenomics. 2011. PMID: 22008051

5

Dealing with missing outcome data in randomized trials and observational studies.

Groenwold RH, Donders AR, Roes KC, Harrell FE Jr, Moons KG. Groenwold RH, et al. Among authors: roes kc. Am J Epidemiol. 2012 Feb 1;175(3):210-7. doi: 10.1093/aje/kwr302. Epub 2011 Dec 23. Am J Epidemiol. 2012. PMID: 22262640

6

Potential of adaptive clinical trial designs in pharmacogenetic research.

van der Baan FH, Knol MJ, Klungel OH, Egberts AC, Grobbee DE, Roes KC. van der Baan FH, et al. Among authors: roes kc. Pharmacogenomics. 2012 Apr;13(5):571-8. doi: 10.2217/pgs.12.10. Pharmacogenomics. 2012. PMID: 22462749

7

Adaptive trials in clinical research: scientific and ethical issues to consider.

van der Graaf R, Roes KC, van Delden JJ. van der Graaf R, et al. Among authors: roes kc. JAMA. 2012 Jun 13;307(22):2379-80. doi: 10.1001/jama.2012.6380. JAMA. 2012. PMID: 22692169 No abstract available.

8

The challenges of determining noninferiority margins: a case study of noninferiority randomized controlled trials of novel oral anticoagulants.

Wangge G, Roes KC, de Boer A, Hoes AW, Knol MJ. Wangge G, et al. Among authors: roes kc. CMAJ. 2013 Feb 19;185(3):222-7. doi: 10.1503/cmaj.120142. Epub 2012 Aug 20. CMAJ. 2013. PMID: 22908144 Free PMC article. No abstract available.

9

Comparing HAMD(17) and HAMD subscales on their ability to differentiate active treatment from placebo in randomized controlled trials.

Boessen R, Groenwold RH, Knol MJ, Grobbee DE, Roes KC. Boessen R, et al. Among authors: roes kc. J Affect Disord. 2013 Mar 5;145(3):363-9. doi: 10.1016/j.jad.2012.08.026. Epub 2012 Sep 7. J Affect Disord. 2013. PMID: 22959683

10

Increasing trial efficiency by early reallocation of placebo nonresponders in sequential parallel comparison designs: application to antidepressant trials.

Boessen R, Knol MJ, Groenwold RH, Grobbee DE, Roes KC. Boessen R, et al. Among authors: roes kc. Clin Trials. 2012 Oct;9(5):578-87. doi: 10.1177/1740774512456454. Clin Trials. 2012. PMID: 23060319 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results